Deep Genomics

Deep Genomics creates its own unique artificial intelligence (AI), which is then used to find fresh approaches to reverse the effects of genetic mutations and create individualized treatments. Brendan Frey, the founder of their company, contributed to the development of the incredibly popular artificial intelligence technique known as "deep learning" in 1995. Everything is changing because of this technology, from farmers producing better crops to cell phones transcribing speech to text.

With more than 100 team members, Deep Genomics has experience in a variety of fields, including molecular genetics, artificial intelligence, automation, cell, and molecular biology, clinical development, in vitro disease models, machine learning, medicine, and software engineering. The top 1% of new graduates and seasoned professionals working at the nexus of genetics, drug development, and AI are who Deep Genetics chooses to hire..

The use of AI and machine learning to mine the human genome for knowledge about how diseases occur and to program medicines to treat them is being pioneered by Deep Genomics. Their in-house developed AI Workbench decodes enormous volumes of RNA biology data, identifies fresh targets for treating genetically determined disorders, and generates top-notch treatment programs to do so. AI Workbench 3.0 is a project that Deep Genomics is currently developing to study increasingly complicated genetic illnesses.

Founded: 2014

Headquarters: Toronto, Canada

Website: https://www.deepgenomics.com/